Low shear stress damages endothelial function through STAT1 in endothelial cells (ECs)

Linlin Zhu1, Feng Wang1, Hongfeng Yang2

  • 1Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Insights

Low shear stress (LSS) activates signal transducer and activator of transcription 1 (STAT1), contributing to endothelial cell damage and cardiovascular disease. Inhibiting STAT1 may offer a therapeutic strategy against atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Endothelial Cell Function
  • Molecular Mechanisms of Atherosclerosis

Background:

  • Low shear stress (LSS) is associated with atherosclerotic lesion development.
  • Signal transducer and activator of transcription 1 (STAT1) is implicated in cardiovascular disease, but its role in LSS is unclear.

Purpose of the Study:

  • To investigate the relationship between LSS and STAT1 activation in endothelial cells (ECs).
  • To elucidate the mechanism by which LSS affects endothelial function via STAT1.

Main Methods:

  • Endothelial cells were subjected to LSS in vitro.
  • Protein expression and phosphorylation analyzed via Western blotting.
  • Immunofluorescence used on human coronary arteries.
  • Endothelial function assessed using dihydroethidium assay, real-time PCR, and NO-sensitive fluorophore.

Main Results:

  • LSS induced STAT1 (Tyr701) phosphorylation in ECs and increased intimal STAT1 expression in human coronary arteries.
  • STAT1 phosphorylation was positively regulated by inhibitor of nuclear factor kappa-B kinase ε (IKKε).
  • Silencing STAT1 (siSTAT1) reversed LSS-induced inflammatory factor expression, increased reactive oxygen species (ROS), and decreased nitric oxide (NO) release, while upregulating heme oxygenase-1 (HO-1) and downregulating eNOS Thr495 phosphorylation.

Conclusions:

  • LSS-mediated endothelial cell injury is linked to STAT1 activation.
  • Targeting STAT1 expression or activation may be a potential therapeutic approach for atherosclerosis.